Search

Your search keyword '"Gottfredsson, Magnús"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Gottfredsson, Magnús" Remove constraint Author: "Gottfredsson, Magnús"
107 results on '"Gottfredsson, Magnús"'

Search Results

1. Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis

2. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

4. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

5. Mortality in Community-Acquired Sepsis and Infections in the Faroe Islands—A Prospective Observational Study.

6. Clinical spectrum of coronavirus disease 2019 in Iceland : population based cohort study

7. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study

8. Estimation of prevalence of chronic HCV infection in EU/EEA countries using multiparameter evidence synthesis

9. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

11. Sustained low prevalence of HCV viremia among people who inject drugs following the treatment as prevention for hepatitis C (TraP HepC) nationwide elimination program in Iceland

12. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences

13. Reply to Mamelund

20. FRI-121 - Estimation of prevalence of chronic HCV infection in EU/EEA countries using multiparameter evidence synthesis

21. No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Iceland

25. Fungal Meningitis

26. THU-412-Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection: Results from the treatment as prevention for hepatitis C (Trap HepC) program

27. PS-072-Is homelessness the biggest hurdle to treatment success in the management of HCV in the era of direct acting antivirals? Results from the TraP HepC nationwide treatment initiative in Iceland

29. Epidemiology of community-acquired sepsis in the Faroe Islands - a prospective observational study.

40. Neisseria meningitidis sequence type and risk for death, Iceland.

41. Risk Factors for Acute Cellulitis of the Lower Limb: A Prospective Case-Control Study.

42. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation

43. Successful Treatment of Candida glabrata Myocarditis with Voriconazole.

44. Determination of in vitro postantibiotic effects in Staphylococcus aureusand Escherichia coliby [3H]thymidine incorporation

45. Focus of infection and microbiological etiology in community-acquired infections in hospitalized adult patients in the Faroe Islands.

47. SAT344 - No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Iceland.

49. Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.

50. [Clostridium difficile infections at Landspítali - 1998-2008].

Catalog

Books, media, physical & digital resources